NO20001483D0 - Nye NPY-agonister - Google Patents

Nye NPY-agonister

Info

Publication number: NO20001483D0
Authority: NO; Norway
Prior art keywords: npy agonists; novel npy; novel; agonists; npy
Prior art date: 1997-09-23

Application number

NO20001483A

Other languages

English (en)

Other versions

NO20001483L (no

Inventor

Nils-Ke Bergman

Ambra Thomas D

Garry Pilling

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-09-23

Filing date

2000-03-22

Publication date

2000-03-22

2000-03-22 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2000-03-22 Publication of NO20001483D0 publication Critical patent/NO20001483D0/no

2000-05-23 Publication of NO20001483L publication Critical patent/NO20001483L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Vascular Medicine (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Emergency Medicine (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20001483A 1997-09-23 2000-03-22 Nye NPY-agonister NO20001483L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9703414A SE9703414D0 (sv)	1997-09-23	1997-09-23	New compounds
PCT/SE1998/001686 WO1999015498A1 (en)	1997-09-23	1998-09-21	New npy antagonists

Publications (2)

Publication Number	Publication Date
NO20001483D0 true NO20001483D0 (no)	2000-03-22
NO20001483L NO20001483L (no)	2000-05-23

Family

ID=20408331

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20001483A NO20001483L (no)	1997-09-23	2000-03-22	Nye NPY-agonister

Country Status (21)

Country	Link
US (1)	US6127414A (no)
EP (1)	EP1017672B1 (no)
JP (1)	JP2001517651A (no)
KR (1)	KR20010024220A (no)
CN (1)	CN1279666A (no)
AR (1)	AR017138A1 (no)
AT (1)	ATE228500T1 (no)
AU (1)	AU9288998A (no)
BR (1)	BR9812492A (no)
CA (1)	CA2303528A1 (no)
DE (1)	DE69809782T2 (no)
EE (1)	EE200000171A (no)
IL (1)	IL134993A0 (no)
IS (1)	IS5410A (no)
NO (1)	NO20001483L (no)
PL (1)	PL339617A1 (no)
SE (1)	SE9703414D0 (no)
SK (1)	SK3602000A3 (no)
TR (1)	TR200000785T2 (no)
WO (1)	WO1999015498A1 (no)
ZA (1)	ZA988353B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9802075D0 (sv) *	1998-06-11	1998-06-11	Astra Ab	New use
US6312898B1 (en) *	1999-04-15	2001-11-06	Hormos Medical Oy, Ltd.	Diagnosis of a person's risk of developing atherosclerosis or diabetic retinopathy based on leucine 7 to proline 7 polymorphism in the prepro-neuropeptide Y gene
SE9902596D0 (sv) *	1999-07-06	1999-07-06	Astra Ab	Pharmaceutically active compounds
EP1095933A1 (en) *	1999-10-30	2001-05-02	Aventis Pharma Deutschland GmbH	Novel N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
SE0101328D0 (sv) *	2001-04-12	2001-04-12	Astrazeneca Ab	Therapeutic treatment
WO2002092566A1 (en) *	2001-05-15	2002-11-21	Taisho Pharmaceutical Co.,Ltd.	Arginine derivatives
US7371871B2 (en)	2003-05-05	2008-05-13	Probiodrug Ag	Inhibitors of glutaminyl cyclase
WO2005049027A2 (en)	2003-11-03	2005-06-02	Probiodrug Ag	Combinations useful for the treatment of neuronal disorders
FR2864830B1 (fr) *	2004-01-06	2006-03-10	Centre Nat Rech Scient	Procede de synthese sur support solide de composes peptidiques, notamment de composes peptidiques comportant un residu arginine
BRPI0507485A (pt)	2004-02-05	2007-07-10	Probiodrug Ag	inibidores novos de glutaminil ciclase
FR2884516B1 (fr) *	2005-04-15	2007-06-22	Cerep Sa	Antagonistes npy, preparation et utilisations
KR100689499B1 (ko) *	2005-10-26	2007-03-02	삼성전자주식회사	휴대단말기에서 키 설정 정보 디스플레이 방법
WO2007064272A1 (en) *	2005-11-29	2007-06-07	Astrazeneca Ab	Benzhydryl amide derivatives as cannabinoid receptor antagonists or inverse agonists
WO2008055945A1 (en)	2006-11-09	2008-05-15	Probiodrug Ag	3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
ATE554085T1 (de)	2006-11-30	2012-05-15	Probiodrug Ag	Neue inhibitoren von glutaminylcyclase
EA200901140A1 (ru)	2007-03-01	2010-04-30	Пробиодруг Аг	Новое применение ингибиторов глутаминилциклазы
JP5667440B2 (ja)	2007-04-18	2015-02-12	プロビオドルグエージー	グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体
CN102695546B (zh)	2009-09-11	2014-09-10	前体生物药物股份公司	作为谷氨酰胺酰环化酶抑制剂的杂环衍生物
US9181233B2 (en)	2010-03-03	2015-11-10	Probiodrug Ag	Inhibitors of glutaminyl cyclase
US8269019B2 (en)	2010-03-10	2012-09-18	Probiodrug Ag	Inhibitors
JP5945532B2 (ja)	2010-04-21	2016-07-05	プロビオドルグエージー	グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体
US8530670B2 (en)	2011-03-16	2013-09-10	Probiodrug Ag	Inhibitors
PL3461819T3 (pl)	2017-09-29	2020-11-30	Probiodrug Ag	Inhibitory cyklazy glutaminylowej
WO2024112612A1 (en) *	2022-11-23	2024-05-30	Radionetics Oncology, Inc.	Neuropeptide y1 receptor (npy1r) targeted therapeutics and uses thereof
TW202535356A (zh) *	2023-12-28	2025-09-16	美商萊迪奧尼提斯腫瘤醫學公司	神經肽y1受體(npy1r)靶向治療劑及其用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5873821A (en) *	1992-05-18	1999-02-23	Non-Invasive Technology, Inc.	Lateralization spectrophotometer
DE4326465A1 (de) *	1993-01-20	1995-02-09	Thomae Gmbh Dr K	Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE19544687A1 (de) *	1995-11-30	1997-06-05	Thomae Gmbh Dr K	Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE19544686A1 (de) *	1995-11-30	1997-06-05	Thomae Gmbh Dr K	Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
WO1997025041A1 (en) *	1996-01-09	1997-07-17	Eli Lilly And Company	Benzimidzolyl neuropeptide y receptor antagonists
JP4106711B2 (ja) *	1996-03-21	2008-06-25	萬有製薬株式会社	アミノピリジン誘導体
WO1997046250A1 (en) *	1996-06-04	1997-12-11	Synaptic Pharmaceutical Corporation	Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
WO1998003493A1 (en) *	1996-07-23	1998-01-29	Neurogen Corporation	Certain substituted benzylamine derivatives; a new class of neuropeptide-y1 specific ligands
ATE230403T1 (de) *	1996-07-23	2003-01-15	Neurogen Corp	Einige amido- und ammo- substituierte benzylaminderivate: eine neue klasse von neuropeptid y1 spezifische ligande
PT918761E (pt) *	1996-07-23	2003-09-30	Neurogen Corp	Algumas amidas e aminas substituidas com derivados de benzilamina uma nova classe de ligandos especificos do neuropeptido y1
CA2268051A1 (en) *	1996-08-23	1998-02-26	Alanex Corporation	Neuropeptide-y ligands
WO1998024768A1 (en) *	1996-12-03	1998-06-11	Banyu Pharmaceutical Co., Ltd.	Novel urea derivatives
AU5410498A (en) *	1996-12-12	1998-07-03	Banyu Pharmaceutical Co., Ltd.	Pyrazole derivatives
US6166038A (en) *	1996-12-13	2000-12-26	Banyu Pharmaceutical Co., Ltd.	Aminopyrazole derivatives
DE69729315T2 (de) *	1996-12-16	2005-06-23	Banyu Pharmaceutical Co., Ltd.	Aminopyrazolderivate
EP0986553A4 (en) *	1997-02-04	2000-12-27	Bristol Myers Squibb Co	DIHYDROPYRIMIDONE DERIVATIVES AS NPY ANTAGONISTS
CA2251580A1 (en) *	1997-02-14	1998-08-20	Bayer Corporation	Amides as npy5 receptor antagonists
JP2002241368A (ja) *	1997-02-18	2002-08-28	Shionogi & Co Ltd	新規ベンゾラクタム誘導体およびそれを含有する医薬組成物
WO1998040356A1 (en) *	1997-03-12	1998-09-17	Banyu Pharmaceutical Co., Ltd.	Drugs containing aminopyridine derivatives as the active ingredient
US5889016A (en) *	1997-06-26	1999-03-30	Bristol-Myers Squibb Company	Dihydropyrimidone derivatives as NPY antagonists

1997
- 1997-09-23 SE SE9703414A patent/SE9703414D0/xx unknown
1998
- 1998-09-11 ZA ZA988353A patent/ZA988353B/xx unknown
- 1998-09-21 US US09/171,779 patent/US6127414A/en not_active Expired - Fee Related
- 1998-09-21 WO PCT/SE1998/001686 patent/WO1999015498A1/en not_active Ceased
- 1998-09-21 CA CA002303528A patent/CA2303528A1/en not_active Abandoned
- 1998-09-21 IL IL13499398A patent/IL134993A0/xx unknown
- 1998-09-21 TR TR2000/00785T patent/TR200000785T2/xx unknown
- 1998-09-21 SK SK360-2000A patent/SK3602000A3/sk unknown
- 1998-09-21 AU AU92889/98A patent/AU9288998A/en not_active Abandoned
- 1998-09-21 DE DE69809782T patent/DE69809782T2/de not_active Expired - Fee Related
- 1998-09-21 PL PL98339617A patent/PL339617A1/xx unknown
- 1998-09-21 BR BR9812492-7A patent/BR9812492A/pt not_active IP Right Cessation
- 1998-09-21 KR KR1020007003029A patent/KR20010024220A/ko not_active Withdrawn
- 1998-09-21 CN CN98811336A patent/CN1279666A/zh active Pending
- 1998-09-21 EP EP98945708A patent/EP1017672B1/en not_active Expired - Lifetime
- 1998-09-21 EE EEP200000171A patent/EE200000171A/xx unknown
- 1998-09-21 AT AT98945708T patent/ATE228500T1/de not_active IP Right Cessation
- 1998-09-21 JP JP2000512808A patent/JP2001517651A/ja active Pending
- 1998-09-22 AR ARP980104740A patent/AR017138A1/es unknown
2000
- 2000-03-20 IS IS5410A patent/IS5410A/is unknown
- 2000-03-22 NO NO20001483A patent/NO20001483L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ZA988353B (en)	1999-03-23
DE69809782D1 (de)	2003-01-09
IL134993A0 (en)	2001-05-20
EP1017672A1 (en)	2000-07-12
TR200000785T2 (tr)	2000-09-21
SE9703414D0 (sv)	1997-09-23
IS5410A (is)	2000-03-20
EP1017672B1 (en)	2002-11-27
EE200000171A (et)	2001-04-16
CN1279666A (zh)	2001-01-10
KR20010024220A (ko)	2001-03-26
PL339617A1 (en)	2001-01-02
JP2001517651A (ja)	2001-10-09
NO20001483L (no)	2000-05-23
US6127414A (en)	2000-10-03
SK3602000A3 (en)	2001-01-18
WO1999015498A1 (en)	1999-04-01
CA2303528A1 (en)	1999-04-01
AU9288998A (en)	1999-04-12
ATE228500T1 (de)	2002-12-15
BR9812492A (pt)	2000-09-26
DE69809782T2 (de)	2003-07-17
AR017138A1 (es)	2001-08-22

Publication	Publication Date	Title
NO20001483D0 (no)	2000-03-22	Nye NPY-agonister
EP0984779A4 (en)	2000-05-10	SOMATOSTATIN AGONISTS
DK0973746T3 (da)	2004-02-02	Substituerede 3-cyanoquinoliner
ID22271A (id)	1999-09-23	Turunan-turunan 2-(purin-9-il) tetrahidrofuran-3,4-diol
NO20000312L (no)	2000-03-21	Nye forbindelser
NO20001938D0 (no)	2000-04-13	Nye aryloksy-alkyl-dialkylaminer
MX209959B (es)	2002-08-26	4-(3-heterociclil-1-benzoil)pirazoles
NO970512D0 (no)	1997-02-05	Nye heteroaryl-oksazolidinoner
NO993629L (no)	1999-09-27	Epoksy-polysiloksanpolymerblanding
NO20002787D0 (no)	2000-05-31	Nye forbindelser
ATE277050T1 (de)	2004-10-15	Trizyclische vasopressin agoniste
ID23761A (id)	2000-05-11	Trisiklik tersubstitusi
NO961887D0 (no)	1996-05-09	-adrenergiske agonister
DK1137493T3 (da)	2004-07-26	Forkompressionssystem
DE69838285D1 (de)	2007-10-04	Optischer Zirkulator
DE59813487D1 (de)	2006-05-24	Substituierte 4-benzoyl-pyrazole
DE59902764D1 (de)	2002-10-24	Antriebsrolle
ID30056A (id)	2001-11-01	Agonis-agonis 5-htif
ATA205598A (de)	2003-04-15	Rangieranlage
NO305410B1 (no)	1999-05-25	B°lgekraftverk
DE69826440D1 (de)	2004-10-28	Kronenether derivatisierte perylene
DE59710430D1 (de)	2003-08-14	Substituierte 4-benzoyl-pyrazole
DE59912532D1 (de)	2005-10-13	Substituierte acylaminophenyl-uracile
DE59807877D1 (de)	2003-05-15	Substituierte 4-benzoyl-pyrazole
DE59806726D1 (de)	2003-01-30	T-butylperoxy-cyclododecyl-oxalat

Legal Events

Date	Code	Title	Description
2002-06-03	FC2A	Withdrawal, rejection or dismissal of laid open patent application